Navellier & Associates’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-1,300	Closed	-$390K	–	351
2014 Q1	$390K	Sell	1,300 -1	-0.1%	-$300	0.02%	214
2013 Q4	$358K	Buy	1,301 +95	+8%	+$26.1K	0.02%	231
2013 Q3	$377K	Sell	1,206 -19	-2%	-$5.94K	0.01%	212
2013 Q2	$275K	Buy	+1,225	New	+$275K	0.01%	220